N
Nicola Coley
Researcher at University of Toulouse
Publications - 81
Citations - 2912
Nicola Coley is an academic researcher from University of Toulouse. The author has contributed to research in topics: Dementia & Cognitive decline. The author has an hindex of 26, co-authored 70 publications receiving 2241 citations. Previous affiliations of Nicola Coley include Paul Sabatier University & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
Sandrine Andrieu,Sandrine Andrieu,Sophie Guyonnet,Sophie Guyonnet,Nicola Coley,Nicola Coley,Christelle Cantet,Christelle Cantet,Marc Bonnefoy,Serge Bordes,Lawrence Bories,Marie-Noëlle Cufi,Thierry Dantoine,Jean-François Dartigues,Françoise Desclaux,Audrey Gabelle,Audrey Gabelle,Yannick Gasnier,Alain Pesce,Kristel Sudres,Jacques Touchon,Jacques Touchon,Philippe Robert,Olivier Rouaud,Philippe Legrand,Pierre Payoux,Jean-Paul Caubere,Michael W. Weiner,Isabelle Carrié,Pierre-Jean Ousset,Pierre-Jean Ousset,Bruno Vellas,Bruno Vellas,Lauréane Brigitte,Catherine Faisant,Françoise Lala,Julien Delrieu,H. Villars,Emeline Combrouze,Carole Badufle,Audrey Zueras,Christophe Morin,Gabor Abellan van Kan,Charlotte Dupuy,Yves Rolland,Céline Caillaud,Bertrand Fougère,Sherry L. Willis,Sylvie Belleville,Brigitte Gilbert,Francine Fontaine,Isabelle Marcet,Fleur Delva,Alexandra Foubert,Sandrine Cerda,Marie Noëlle-Cuffi,Corinne Costes,Patrick Manckoundia,Valérie Quipourt,Sophie Marilier,Evelyne Franon,Marie-Laure Pader,Marie-France Basset,Bruno Lapoujade,Valérie Faure,Michael Li,Yung Tong,Christine Malick-Loiseau,Evelyne Cazaban-Campistron,Colette Blatge,Cécile Laubarie-Mouret,Isabelle Saulnier,Jean-Pierre Clément,Marie-Agnès Picat,Laurence Bernard-Bourzeix,Stéphanie Willebois,Ileana Desormais,Noëlle Cardinaud,Pierre Livet,Pascale Rebaudet,Claire Gédéon,Catherine Burdet,Flavien Terracol,Stéphanie Roth,Sylvie Chaillou,Sandrine Louchart,Nicolas Lebrun,Nadège Barro-Belaygues,Karim Bennys,Aurélia Romano,Lynda Touati,Cecilia Marelli,Cécile Pays,Franck Le Duff,Claire Gervais,Sebastien Gonfrier,Danièle Begorre,Christian Carpuat,Khaled Khales,Jean-François Lefebvre,Samira Misbah El Idrissi,Pierre Skolil,Jean-Pierre Salles,Carole Dufouil,Stéphane Lehéricy,Marie Chupin,Jean-François Mangin,Ali Bouhayia,Michèle Allard,Frédéric Ricolfi,Dominique Dubois,Marie Paule,Bonceour Martel,François Cotton,Alain Bonafe,Stéphane Chanalet,Françoise Hugon,Fabrice Bonneville,Christophe Cognard,François Chollet,Thierry Voisin,Sophie Peiffer,Anne Hitzel,Michel Zanca,Jacques Monteil,Jacques Darcourt,Laurent Molinier,Hélène Derumeaux,N. Costa,Christian Vincent,Bertrand Perret,Claire Vinel,Pascale Olivier-Abbal +132 more
TL;DR: The multidomain intervention and polyunsaturated fatty acids, either alone or in combination, had no significant effects on cognitive decline over 3 years in elderly people with memory complaints.
Journal ArticleDOI
Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial.
Bruno Vellas,Bruno Vellas,Nicola Coley,Nicola Coley,Pierre-Jean Ousset,Pierre-Jean Ousset,Gilles Berrut,Jean-François Dartigues,Bruno Dubois,Hélène Grandjean,Florence Pasquier,François Piette,Philippe Robert,Jacques Touchon,Philippe Garnier,Hélène Mathiex-Fortunet,Sandrine Andrieu +16 more
TL;DR: Long-term use of standardised ginkgo biloba extract in this trial did not reduce the risk of progression to Alzheimer's disease compared with placebo.
Journal ArticleDOI
Dementia Prevention: Methodological Explanations for Inconsistent Results
Nicola Coley,Nicola Coley,Sandrine Andrieu,Virginie Gardette,Sophie Gillette-Guyonnet,Sophie Gillette-Guyonnet,Caroline Sanz,Bruno Vellas,Alain Grand +8 more
TL;DR: The aim of this paper is to review the epidemiologic data linking potential protective factors to dementia or cognitive decline and to discuss the methodological limitations that could explain conflicting results.
Journal ArticleDOI
Endpoints for trials in Alzheimer's disease: a European task force consensus.
Bruno Vellas,Bruno Vellas,Sandrine Andrieu,Sandrine Andrieu,Cristina Sampaio,Nicola Coley,Nicola Coley,Gordon K. Wilcock +7 more
TL;DR: This work presents a consensus for endpoints to be used in clinical trials in Alzheimer's disease, agreed by a European task force under the auspices of the European Alzheimer Disease Consortium, and suggests suitable endpoints for primary and secondary prevention trials, and for symptomatic and disease-modifying trials in very early, mild, and moderate Alzheimer's Disease.
Journal ArticleDOI
Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials
Jesse M. Cedarbaum,Mark Jaros,Chito Hernandez,Nicola Coley,Sandrine Andrieu,Michael Grundman,Bruno Vellas +6 more
TL;DR: The database of the Alzheimer's Disease Neuroimaging Initiative is used to explore the psychometric properties of the Clinical Dementia Rating Sum of Boxes to consider its utility as an outcome measure for clinical trials in early and mild, as well as later, stages of Alzheimer's disease.